Superficial Acral Fibromyxoma: A Report of Two Cases with CD68 Expression
Qingan Huang,Yuan Li,Mu Niu,Gaihe Chen
DOI: https://doi.org/10.2147/ccid.s441055
2024-01-18
Clinical Cosmetic and Investigational Dermatology
Abstract:Qingan Huang, 1, &ast Yuan Li, 2, 3, &ast Mu Niu, 2 Gaihe Chen 4 1 Department of General Ward, the Fifth People's Hospital of Hainan Province, Haikou, Hainan, People's Republic of China; 2 Department of Cosmetic Dermatology, the Fifth People's Hospital of Hainan Province, Haikou, Hainan, People's Republic of China; 3 Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 4 Department of Dermatology, the Fifth People's Hospital of Hainan Province, Haikou, Hainan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gaihe Chen, Department of Dermatology, the Fifth People's Hospital of Hainan Province, No. 8 Longhua Road, Longhua District, Haikou, Hainan, 570100, People's Republic of China, Email Mu Niu, Department of Cosmetic Dermatology, the Fifth People's Hospital of Hainan Province, No. 8 Longhua Road, Longhua District, Haikou, Hainan, 570100, People's Republic of China, Email Superficial Acral fibroma (SAF), also known as osteofibroma, is a rare fibromatous tumor primarily involving superficial soft tissues. Clinically, SAF typically manifests as a slow-growing, solitary, well-defined nodule or mass. Although these lesions are generally asymptomatic, some cases may present with associated pain, often linked to a history of trauma. SAF lesions commonly exhibit hemispherical, polypoid, or warty growths, with occasional occurrences of ulceration and bleeding.The majority of SAFs express CD34 and CD99, but in the two cases we report, there was diffuse expression of CD34 and focal positive expression of CD68. CD68 positivity suggests a propensity for tumor cells to metastasize to secondary sites. Notably, previously reported cases of single SAF did not display positive CD68 expression, indicating a potential association with other aggressive tumors. However, the current clinical and pathological manifestations do not clarify the diagnosis of additional malignant tumors. Consequently, regular postoperative monitoring of the patient from the aforementioned two cases is essential to detect the presence of other malignant tumors. The significance of CD68-positive expression in this case lies in its potential association with such tumors. Keywords: superficial acral fibromyxoma, immunohistochemistry, CD34, CD68 Superficial Acral Fibromyxoma (SAF), also known as fibromyxoma of the digits and toes, is a rare soft-tissue fibromyxomatous tumor. It was first reported by Fetsch et al in 2001. 1 This tumor predominantly affects adult males and typically develops in the subungual and periungual areas of the digits and toes. Clinical manifestations include slow-growing, solitary, well-defined nodules or lumps, most of which are asymptomatic. Some patients may experience pain, and a few cases are associated with a history of trauma. These nodules often present a hemispherical, polypoid, or warty proliferative appearance; some may exhibit ulceration and bleeding. Clinicians should carefully differentiate SAF from other conditions, such as dermatocysts, neurofibromas, dermatocystadenomas, and fibromas. 2 Histopathological examination reveals several distinctive features of SAF. The tumor comprises spindle-shaped to star-shaped fibroblast-like cells, irregularly distributed within a mucus-like stroma. In certain areas, the tumor cells may form bundles or loose mats. Abundant ciliated blood vessels are present within the mucus-like stroma, and scattered mast cells can be observed. The abnormalities in the tumor cells were generally mild, featuring few instances of nuclear schizophrenia and minimal necrosis. Immunohistochemical analysis revealed the expression of waveform proteins, CD34, and CD99 in spindle and astrocytes. Additionally, there was focal expression of CD10, 3 while no CD68 expression was observed. In contrast, we present two cases with diffuse expression of CD34 and positive focal expression of CD68.Positive expression of CD68 serves as a potential marker for tumor metastasis. Despite being a benign tumor that grows relatively slowly and rarely metastasizes, Superficial rostral fibroma (SAF) exhibited focal positive staining of CD68 in these two cases we report. This observation suggests a potential association of the tumor with other aggressive tumors. Therefore, regular postoperative follow-up of this patient is essential to monitor for the presence of other malignant tumors. The patient received a diagnosis between November 2022 and March 2023 following an outpatient visit, histopathologic biopsy, and confirmation through immunohistochemistry for the suspected disease. The specimens were surgically excised and fixed in a 10% n -Abstract Truncated-
dermatology